- 米国企業
- Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc.ALLO
時価総額
$4.7億
PER
2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
Collaboration revenue - related party | - | - | - | 38 | 0 |
Research and development | - | - | 193 | 220 | 256 |
General and administrative | - | - | 65 | 74 | 79 |
Total operating expenses | - | - | 258 | 294 | 336 |
Loss from operations | - | - | -258 | -256 | -335 |
Interest and Other Income | - | - | - | - | 5 |
Other expenses | - | - | 9 | 2 | -2 |
Total other income (expense), net | - | - | 8 | -1 | 3 |
Net loss | -212 | -185 | -250 | -257 | -333 |
Net unrealized loss on available-for-sale investments | - | - | -1 | -3 | -7 |
Net comprehensive loss | - | - | -251 | -260 | -340 |
Earnings Per Share, Basic | - | - | - | -1.89 | -2.32 |
Earnings Per Share, Diluted | - | - | - | -1.89 | -2.32 |